All In Biotech

Free tool

FAERS Monitor: Climara

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020375 or its brand name (Climara, Estradiol). Reports on generic versions are filed under their own applications.

Reports

57,593

Serious

24,115

42% of reports

Hospitalization

7,644

Death reported

958

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • product adhesion issue5,459
  • drug ineffective5,040
  • headache3,312
  • nausea3,167
  • fatigue3,124
  • off label use2,704
  • hot flush2,356
  • pain2,237
  • diarrhoea2,071
  • dizziness1,911
  • breast cancer female1,833
  • rash1,825
  • arthralgia1,783
  • pruritus1,777
  • insomnia1,647

Reports by year received

View as table
YearReports
2004612
2005703
2006535
20071,547
20081,032
2009864
20101,164
20111,184
20121,414
20131,075
20141,321
20152,351
20162,855
20172,725
20183,011
20193,511
20203,484
20213,486
20223,548
20234,070
20244,307
20256,292
20266,501

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,996,566 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
product adhesion issueSignal5,45965.763.9295,028
breast cancer femaleSignal1,83326.825.642,489
hot flushSignal2,35611.811.322,522
insomniaSignal1,6472.32.21,171
headache3,3121.91.91,531
pruritus1,7771.71.6509
arthralgia1,7831.61.5373
rash1,8251.51.5341
fatigue3,1241.51.4480
nausea3,1671.51.4480
dizziness1,9111.41.3223
drug ineffective5,0401.41.4607
pain2,2371.31.3189
diarrhoea2,0711.21.154
off label use2,7041.11.141

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.